These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8102155)

  • 21. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
    J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells.
    De Maria A; Colombini S; Schnittman SM; Moretta L
    Eur J Immunol; 1994 Mar; 24(3):531-6. PubMed ID: 7907291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
    Nickell SP; Stryker GA; Arevalo C
    J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of an overlapping CD8+ and CD4+ T-cell epitope on rubella capsid protein.
    Ou D; Mitchell LA; Décarie D; Gillam S; Tingle AJ
    Virology; 1997 Sep; 235(2):286-92. PubMed ID: 9281508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of antigen-specific CD8+ CTLs from naive precursors.
    Mehta-Damani A; Markowicz S; Engleman EG
    J Immunol; 1994 Aug; 153(3):996-1003. PubMed ID: 8027569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.
    Lütjen S; Soltek S; Virna S; Deckert M; Schlüter D
    Infect Immun; 2006 Oct; 74(10):5790-801. PubMed ID: 16988257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
    Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
    J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between direct binding ability of synthetic T. gondii SAG1 peptides to HLA-A2 measured by a sensor for surface plasmon resonance and antigenicity of the peptides for T. gondii-infected cell-specific CTL.
    Yano A; Aosai F; Yang TH; He N; Mun HS; Liu H; Inoko H; Norose K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):257-61. PubMed ID: 9240420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
    Bass HZ; Yamashita N; Clement LT
    J Immunol; 1993 Sep; 151(6):2895-903. PubMed ID: 8376760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.